Related Experiment Video
Updated: May 15, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Characteristics of multidrug-resistant tuberculosis in Namibia
Philip M Ricks1, Farai Mavhunga, Surbhi Modi
1Centers for Disease Control and Prevention, Atlanta, GA, USA. hgp4@cdc.gov
Previous TB treatment, hospitalization, and household MDR-TB exposure significantly increase multidrug-resistant tuberculosis (MDR-TB) risk in Namibia. Inadequate TB control practices require urgent strengthening to prevent MDR-TB spread.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health threat.
- Understanding the epidemiology and risk factors for MDR-TB in specific regions like Namibia is crucial for effective control.
Purpose of the Study:
- To investigate the epidemiological characteristics of MDR-TB in Namibia.
- To identify potential risk factors associated with the development of MDR-TB.
Main Methods:
- A case-control study was conducted using medical records and patient questionnaires.
- Cases were defined as laboratory-confirmed MDR-TB patients, and controls had drug-susceptible TB or were on standard treatment regimens.
- The study included 117 MDR-TB cases and 251 TB controls diagnosed between January 2007 and March 2009.
Main Results:
- Previous TB treatment was strongly associated with MDR-TB (OR 28.7).
- MDR-TB cases were more likely to have a history of hospitalization (OR 1.9) and a household member with MDR-TB (OR 5.1).
- These associations remained significant even after controlling for current hospitalization or HIV infection.
Conclusions:
- Previous TB treatment, prior hospitalization, and household MDR-TB exposure are significant risk factors for developing MDR-TB in Namibia.
- Findings suggest deficiencies in current TB control practices.
- Strengthening basic TB control measures, including laboratory confirmation, directly observed therapy, and infection control, is essential for MDR-TB prevention.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Development of Antibiotic Resistance
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
